Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor
- PMID: 12717013
- PMCID: PMC2323861
- DOI: 10.1110/ps.0235703
Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor
Abstract
We studied the non-native aggregation of recombinant human granulocyte stimulating factor (rhGCSF) in solution conditions where native rhGCSF is both conformationally stable compared to its unfolded state and at concentrations well below its solubility limit. Aggregation of rhGCSF first involves the perturbation of its native structure to form a structurally expanded transition state, followed by assembly process to form an irreversible aggregate. The energy barriers of the two steps are reflected in the experimentally measured values of free energy of unfolding (DeltaG(unf)) and osmotic second virial coefficient (B(22)), respectively. Under solution conditions where rhGCSF conformational stability dominates (i.e., large DeltaG(unf) and negative B(22)), the first step is rate-limiting, and increasing DeltaG(unf) (e.g., by the addition of sucrose) decreases aggregation. In solutions where colloidal stability is high (i.e., large and positive B(22) values) the second step is rate-limiting, and solution conditions (e.g., low pH and low ionic strength) that increase repulsive interactions between protein molecules are effective at reducing aggregation. rhGCSF aggregation is thus controlled by both conformational stability and colloidal stability, and depending on the solution conditions, either could be rate-limiting.
Figures







Similar articles
-
Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition.Biochemistry. 2002 May 21;41(20):6422-31. doi: 10.1021/bi012006m. Biochemistry. 2002. PMID: 12009905
-
Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor.J Pharm Sci. 2006 Jul;95(7):1480-97. doi: 10.1002/jps.20619. J Pharm Sci. 2006. PMID: 16729274
-
Relationship between native-state solubility and non-native aggregation of recombinant human granulocyte colony stimulating factor: practical implications for protein therapeutic development.Mol Pharm. 2014 Oct 6;11(10):3431-42. doi: 10.1021/mp500165j. Epub 2014 Aug 29. Mol Pharm. 2014. PMID: 25144791
-
Colloidal behavior of proteins: effects of the second virial coefficient on solubility, crystallization and aggregation of proteins in aqueous solution.Curr Pharm Biotechnol. 2005 Dec;6(6):427-36. doi: 10.2174/138920105775159313. Curr Pharm Biotechnol. 2005. PMID: 16375727 Review.
-
Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).Eur J Cancer. 1994;30A Suppl 3:S7-11. Eur J Cancer. 1994. PMID: 7535073 Review.
Cited by
-
With or without sugar? (A)glycosylation of therapeutic antibodies.Mol Biotechnol. 2013 Jul;54(3):1056-68. doi: 10.1007/s12033-012-9612-x. Mol Biotechnol. 2013. PMID: 23097175 Review.
-
Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.Adv Drug Deliv Rev. 2021 May;172:211-233. doi: 10.1016/j.addr.2021.02.016. Epub 2021 Mar 8. Adv Drug Deliv Rev. 2021. PMID: 33705880 Free PMC article. Review.
-
Structure and thermodynamics of colloidal protein cluster formation: comparison of square-well and simple dipolar models.J Chem Phys. 2009 Sep 28;131(12):125104. doi: 10.1063/1.3238569. J Chem Phys. 2009. PMID: 19791922 Free PMC article.
-
Experimental and Computational Analysis of Protein Stabilization by Gly-to-d-Ala Substitution: A Convolution of Native State and Unfolded State Effects.J Am Chem Soc. 2016 Dec 7;138(48):15682-15689. doi: 10.1021/jacs.6b09511. Epub 2016 Nov 21. J Am Chem Soc. 2016. PMID: 27934019 Free PMC article.
-
Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Vaccine. 2017 Oct 4;35(41):5471-5480. doi: 10.1016/j.vaccine.2017.03.101. Epub 2017 May 24. Vaccine. 2017. PMID: 28551040 Free PMC article.
References
-
- Atkins, P. 1994. Physical chemistry, 5th ed., p. 1031. W.H. Freeman and Company, New York.
-
- B.I. Corporation. 1993. Instrument manual for BI-ZP software, version 4.0 & higher and BI-9025AT & BI-2025AT signal processors, version 1.1.b. Holtsville, NY.
-
- Chang, R.C., Asthagiri, D., and Lenhoff, A.M. 2000. Measured and calculated effects of mutations in bacteriophage T4 lysozyme on interactions in solution. Proteins 41 123–132. - PubMed
-
- Dong, A.C., Meyer, J.D., Brown, J.L., Manning, M.C., and Carpenter, J.F. 2000. Comparative Fourier transform infrared and circular dichroism spectroscopic analysis of α(1)-proteinase inhibitor and ovalbumin in aqueous solution. Arch. Biochem. Biophys. 383 148–155. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources